COMMITTEES
Global Collaboration and Partnerships
Committee Purpose:
Dedicated to uniting the global community of vaccinologists
- Engage and partner with vaccine groups globally.
- Promote communication and collaboration among organizations who seek to innovate, develop, manufacture, and enhance vaccines.
- Promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.
- Engage ISV Fellows to build and promote ISV.
Shan Lu
Worcester HIV Vaccine (Chair)
Denise Doolan
University of Queensland
Alexander Bukreyev
The University of Texas Medical Branch at Galveston
Kopek Nihlmark
Karolinska Institute
Davinder Gill
StiRx Inc
Partners
International AIDS Society IAS
Global HIV Vaccine Enterprise
The International AIDS Society (IAS) is the world’s largest association of HIV professionals, bringing together scientists, clinicians, policymakers, and advocates to advance HIV research, influence global policy, and ensure equitable access to prevention, treatment, and care. Through major conferences and evidence-based initiatives, IAS drives the global response to end AIDS as a public health threat.
- Co-organizer of the ISV Mini-Symposium on HIV Vaccines (June 2025)
International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a treaty-based international organization established in 1997 with a not-for-profit mission to discover, develop, and deliver safe, effective, and affordable vaccines—empowering vaccine equity, impact, and sustainability globally.
- Co-organizer of ISV Congress 2024 and Partner for ISV Congress 2025
IVVN International Veterinary Vaccinology Network from the UK
The IVVN seeks to kindle and foster these essential collaborations. With our unique remit, we aim to help researchers, industrial partners and others work together towards developing vaccines specifically for high-consequence livestock (including poultry and aquaculture) diseases in LMICs.
https://www.intvetvaccnet.co.uk/
- Partner for ISV Congress 2024 & 2025
Flanders Vaccine
Flanders Vaccine provides a unique platform that connects diverse stakeholders while offering access to expertise, cutting-edge technologies, and essential resources to advance vaccine research and development. Leveraging our extensive network, we foster cross-disciplinary collaborations, support groundbreaking research, and facilitate the translation of scientific discoveries.
- Sponsor of ISV 2019 Congress.
The Sealy Institute for Vaccine Sciences of UTMB
In December 2001 the Sealy Center for Vaccine Development (SCVD) was established at UTMB. In January 2018, vaccine research and development expanded at UTMB with the inauguration of the Sealy Institute for Vaccine Sciences (SIVS). The SIVS will help support and guide the development of prophylactic and therapeutic vaccines at UTMB.
Instituto Butantan from Brazil
With 123 years of history, Butantan works to prevent diseases like Covid-19, flu, tetanus, diphtheria, hepatitis A and B, chikungunya, whooping cough, dengue, HPV and rabies.
Coming soon: Annual Virtual Conference of ISV Partners
To be held online one day before the opening of 2025 ISV Congress.
ISV Global Vaccine Partners will share their work and progress (open to everyone).
